(Q38243926)

31 August 2017

Risk factors for severe or fatal drug-induced liver injury from amoxicillin-clavulanic acid (English)

1 reference

31 August 2017

Cemal Yazici

1

1 reference

31 August 2017

Ece Mutlu

series ordinal

2

1 reference

31 August 2017

Herbert L Bonkovsky

series ordinal

3

1 reference

31 August 2017

Mark W Russo

series ordinal

4

1 reference

31 August 2017

7 October 2014

1 reference

31 August 2017

1 reference

31 August 2017

45

1 reference

31 August 2017

6

1 reference

31 August 2017

676-682

1 reference

Co-amoxiclav jaundice: clinical and histological features and HLA class II association.

31 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12410

Amoxycillin/clavulanic acid (Augmentin)-induced intrahepatic cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12410

HLA association of amoxicillin-clavulanate--induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12410

Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12410

Cholestatic hepatitis due to antibacterial combination of amoxicillin and clavulanic acid (augmentin)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12410

Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12410

Antibiotic therapy: a major cause of drug-induced jaundice in southwest England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12410

Amoxicillin-clavulanic acid hepatotoxicity in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12410

Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12410

Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12410

Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12410

Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12410

Intrahepatic cholestasis without hepatitis induced by amoxycillin/clavulanic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12410

Hepatocellular-cholestatic liver injury due to amoxycillin-clavulanic acid combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12410

Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12410

Drug-induced liver injury in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12410

HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12410

Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12410

Investigation of PK-PD drug-drug interaction between acenocoumarol and amoxicillin plus clavulanic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12410

Modeling drug- and chemical-induced hepatotoxicity with systems biology approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12410

21 January 2018

Identifiers

DOI

10.1111/HEPR.12410

1 reference

31 August 2017

1 reference